Direct effects of iodothyronines on excess fat storage in rat hepatocytes

Adams, 2005, Recent concepts in non-alcoholic fatty liver disease, Diabet Med, 22, 1129, 10.1111/j.1464-5491.2005.01748.x

Adams, 2006, Treatment of non-alcoholic fatty liver disease, Postgrad Med J, 82, 315, 10.1136/pgmj.2005.042200

Donnelly, 2005, Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J Clin Invest, 115, 1343, 10.1172/JCI23621

Bradbury, 2006, Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis, Am J Physiol Gastrointest Liver Physiol, 290, G194, 10.1152/ajpgi.00413.2005

Grasselli, 2010, PAT protein mRNA expression in primary rat hepatocytes: effects of exposure to fatty acids, Int J Mol Med, 25, 505

Motomura, 2006, Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet, Biochem Biophys Res Commun, 340, 1111, 10.1016/j.bbrc.2005.12.121

Targett-Adams, 2005, A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein, Biochim Biophys Acta, 1728, 95, 10.1016/j.bbaexp.2005.01.017

Lanni, 2003, Thyroid hormone and uncoupling proteins, FEBS Lett, 543, 5, 10.1016/S0014-5793(03)00320-X

Silva, 2003, The thermogenic effect of thyroid hormone and its clinical implications, Ann Intern Med, 139, 205, 10.7326/0003-4819-139-3-200308050-00018

Cimmino, 1996, Demonstration of in vivo metabolic effects of 3, 5-di-iodothyronine, J Endocrinol, 149, 319, 10.1677/joe.0.1490319

Moreno, 1998, Effect of 3, 5-diiodo-L-thyronine on thyroid stimulating hormone and growth hormone serum levels in hypothyroid rats, Life Sci, 62, 2369, 10.1016/S0024-3205(98)00219-7

Lanni, 2005, 3, 5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats, Faseb J, 19, 1552, 10.1096/fj.05-3977fje

Grasselli, 2008, Effects of 3, 5-diiodo-L-thyronine administration on the liver of high fat diet-fed rats, Exp Biol Med (Maywood), 233, 549, 10.3181/0710-RM-266

Mollica, 2009, 3, 5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet, J Hepatol, 51, 363, 10.1016/j.jhep.2009.03.023

Giudetti, 2005, Short-term stimulation of lipogenesis by 3, 5-L-diiodothyronine in cultured rat hepatocytes, Endocrinology, 146, 3959, 10.1210/en.2005-0345

Suh, 2008, Linoleic acid stimulates gluconeogenesis via Ca2+/PLC, cPLA2, and PPAR pathways through GPR40 in primary cultured chicken hepatocytes, Am J Physiol Cell Physiol, 295, C1518, 10.1152/ajpcell.00368.2008

Vinciguerra, 2009, Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes, Hepatology, 49, 1176, 10.1002/hep.22737

Feldstein, 2004, Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway, Hepatology, 40, 185, 10.1002/hep.20283

Gomez-Lechon, 2007, A human hepatocellular in vitro model to investigate steatosis, Chem Biol Interact, 165, 106, 10.1016/j.cbi.2006.11.004

Araya, 2004, Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease, Clin Sci (Lond), 106, 635, 10.1042/CS20030326

Fugassa, 1983, RNA synthesis in primary cultures of adult rat hepatocytes, In Vitro, 19, 299, 10.1007/BF02619508

Koopman, 2001, Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids, Histochem Cell Biol, 116, 63, 10.1007/s004180100297

Wiechelman, 1988, Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for color formation, Anal Biochem, 175, 231, 10.1016/0003-2697(88)90383-1

Hsu, 1981, Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures, J Histochem Cytochem, 29, 577, 10.1177/29.4.6166661

Mak, 2008, Adipose differentiation-related protein is a reliable lipid droplet marker in alcoholic fatty liver of rats, Alcohol Clin Exp Res, 32, 683, 10.1111/j.1530-0277.2008.00624.x

Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem, 162, 156, 10.1016/0003-2697(87)90021-2

Vergani, 2007, Effects of growth hormone and cadmium on the transcription regulation of two metallothionein isoforms, Mol Cell Endocrinol, 263, 29, 10.1016/j.mce.2006.08.010

Pfaffl, 2001, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res, 29, e45, 10.1093/nar/29.9.e45

Aebi, 1984, Catalase in vitro, Methods Enzymol, 105, 121, 10.1016/S0076-6879(84)05016-3

McCord, 1969, Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein), J Biol Chem, 244, 6049, 10.1016/S0021-9258(18)63504-5

Small, 1985, A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase, Biochem J, 227, 205, 10.1042/bj2270205

Ball, 1997, 3, 5-Diiodo-L-thyronine (T2) has selective thyromimetic effects in vivo and in vitro, J Mol Endocrinol, 19, 137, 10.1677/jme.0.0190137

Ferrannini, 1983, Effect of fatty acids on glucose production and utilization in man, J Clin Invest, 72, 1737, 10.1172/JCI111133

Everett, 2000, The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease, Liver, 20, 191, 10.1034/j.1600-0676.2000.020003191.x

Yoon, 2009, The role of PPARalpha in lipid metabolism and obesity: focusing on the effects of estrogen on PPARalpha actions, Pharmacol Res, 60, 151, 10.1016/j.phrs.2009.02.004

Schadinger, 2005, PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes, Am J Physiol Endocrinol Metab, 288, E1195, 10.1152/ajpendo.00513.2004

Gavrilova, 2003, Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass, J Biol Chem, 278, 34268, 10.1074/jbc.M300043200

de Lange, 2008, Peroxisome proliferator-activated receptor delta: a conserved director of lipid homeostasis through regulation of the oxidative capacity of muscle, PPAR Res., 2008, 172676, 10.1155/2008/172676

Edvardsson, 1999, Rosiglitazone (BRL49653), a PPARgamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice, J Lipid Res, 40, 1177, 10.1016/S0022-2275(20)33479-9

Inoue, 2005, Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice, Biochem Biophys Res Commun, 336, 215, 10.1016/j.bbrc.2005.08.070

Londos, 2005, Role of PAT proteins in lipid metabolism, Biochimie, 87, 45, 10.1016/j.biochi.2004.12.010

Reddy, 1994, Peroxisomal lipid metabolism, Annu Rev Nutr, 14, 343, 10.1146/annurev.nu.14.070194.002015

Kasai, 1989, Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator, Cancer Res, 49, 2603

Mariash, 1983, Interrelationship of triiodothyronine concentration, metabolism, protein binding, and nuclear occupancy in the induction of malic enzyme by cultured adult rat hepatocytes, Endocrinology, 112, 80, 10.1210/endo-112-1-80

Wilson, 1981, Regulation of malic enzyme and mitochondrial alpha-glycerophosphate dehydrogenase by thyroid hormones, insulin, and glucocorticoids in cultured hepatocytes, J Biol Chem, 256, 11657, 10.1016/S0021-9258(19)68455-3

Betley, 1993, Triiodo-L-thyronine stimulates glycogen synthesis in rat hepatocyte cultures, Mol Cell Biochem, 120, 151, 10.1007/BF00926088